Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3069% below fair value
$5.30−0.12 (-2.21%)
Close on Nov 20, 2026Market cap $140.65MP/E –Yield –
Inogen free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Inogen's free cash flow for the twelve months ending Jun 30, 2026 was -$4.98M. For fiscal 2025 it was -$13.74M, down 637.9% from the year before. The highest annual figure on record is $57.58M in fiscal 2017.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.74M | -637.9% |
| FY2024 | Dec 31, 2024 | $2.55M | – |
| FY2023 | Dec 31, 2023 | -$8.45M | – |
| FY2022 | Dec 31, 2022 | -$40.87M | -325.2% |
| FY2021 | Dec 31, 2021 | $18.15M | -44.4% |
| FY2020 | Dec 31, 2020 | $32.63M | -12.9% |
| FY2019 | Dec 31, 2019 | $37.45M | -27.9% |
| FY2018 | Dec 31, 2018 | $51.93M | -9.8% |
| FY2017 | Dec 31, 2017 | $57.58M | +96.4% |
| FY2016 | Dec 31, 2016 | $29.32M | -18.5% |
| FY2015 | Dec 31, 2015 | $35.95M | +154.2% |
| FY2014 | Dec 31, 2014 | $14.15M | +35.5% |
| FY2013 | Dec 31, 2013 | $10.44M | +427.1% |
| FY2012 | Dec 31, 2012 | $1.98M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.24M | -39.0% |
| Q1 FY2026 | Mar 31, 2026 | -$6.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.92M | – |
| Q3 FY2025 | Sep 30, 2025 | $1.60M | -69.9% |
| Q2 FY2025 | Jun 30, 2025 | $3.67M | -44.8% |
| Q1 FY2025 | Mar 31, 2025 | -$17.08M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.35M | – |
| Q3 FY2024 | Sep 30, 2024 | $5.32M | +260.3% |
| Q2 FY2024 | Jun 30, 2024 | $6.64M | +233.6% |
| Q1 FY2024 | Mar 31, 2024 | -$6.06M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.54M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.48M | – |
| Q2 FY2023 | Jun 30, 2023 | $1.99M | -57.3% |
| Q1 FY2023 | Mar 31, 2023 | -$7.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.05M | -375.6% |
| Q3 FY2022 | Sep 30, 2022 | -$10.02M | – |
| Q2 FY2022 | Jun 30, 2022 | $4.66M | -69.3% |
| Q1 FY2022 | Mar 31, 2022 | -$19.46M | -1548.2% |
| Q4 FY2021 | Dec 31, 2021 | $5.82M | -61.6% |
| Q3 FY2021 | Sep 30, 2021 | -$4.21M | -173.5% |
| Q2 FY2021 | Jun 30, 2021 | $15.19M | +19.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.34M | – |
| Q4 FY2020 | Dec 31, 2020 | $15.17M | +78.0% |
| Q3 FY2020 | Sep 30, 2020 | $5.72M | -60.0% |
| Q2 FY2020 | Jun 30, 2020 | $12.68M | -27.1% |
| Q1 FY2020 | Mar 31, 2020 | -$939.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $8.52M | -26.1% |
| Q3 FY2019 | Sep 30, 2019 | $14.30M | +22.4% |
| Q2 FY2019 | Jun 30, 2019 | $17.39M | -6.3% |
| Q1 FY2019 | Mar 31, 2019 | -$2.76M | -127.1% |
| Q4 FY2018 | Dec 31, 2018 | $11.53M | -5.3% |
| Q3 FY2018 | Sep 30, 2018 | $11.68M | -28.2% |
| Q2 FY2018 | Jun 30, 2018 | $18.56M | +12.3% |
| Q1 FY2018 | Mar 31, 2018 | $10.17M | -19.4% |
| Q4 FY2017 | Dec 31, 2017 | $12.18M | +146.1% |
| Q3 FY2017 | Sep 30, 2017 | $16.26M | +84.8% |
| Q2 FY2017 | Jun 30, 2017 | $16.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.95M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.80M | – |
See a number that looks wrong?